Coronavirus vax trial shows promising results
UK researchers report in the Lancet that it's still possible a vaccine could be in use by the end of the year
A SARS-CoV-2 vaccine being developed by a UK university and Astra Zeneca is safe and produces an immune response in early-stage clinical trials, according to new data.
The findings on the vaccine known as AZD1222 have boosted hopes it could be in use by the end of the year.
